Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 71 for “"multiple system atrophy"”.
-
Human brain transcriptomic: towards understanding multiple system atrophy
… targets can be developed. One such disorder is multiple system atrophy (MSA). MSA is a sporadic, rapidly progressing neurodegenerative disease. Currently no treatment exists and very little is known about the molecular basis of MSA. Before an understanding of the diseased brain can be reached an …
-
Pedunculopontine nucleus deep brain stimulation for multiple system atrophy
… Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy.</p> <p><b>Introduction</b></p> Multiple system atrophy is a relentlessly progressive and disabling chronic neurodegenerative disorder. There are currently no known disease modifying treatments, and all available therapy is …
-
Disease modifying therapy for multiple system atrophy – Parkinsonian Type
BACKGROUND: Multiple System Atrophy –Parkinsonian Type (MSA-P) is a rare, rapidly progressive neurodegenerative disease without any current treatment. Recent research has increased the understanding of brain iron accumulation and its association with neurodegenerative synucleinopathies, like MSA-P. …
-
ASSESSING THE PATHOGENESIS OF MULTIPLE SYSTEM ATROPHY THROUGH CELLULAR MODELS
Multiple System Atrophy (MSA) is a severe adult-onset neurodegenerative disease, with an incidence of 0.6 per 100000 persons/year and a survival rate of 6-9 years from the onset. MSA is clinically characterized by parkinsonism, cerebellar ataxia, dysautonomia and pyramidal signs. Two subtypes of …
-
The Application of Mesenchymal Stem Cell therapy on Multiple System Atrophy
Since disease progression in multiple system atrophy(MSA) is much faster and no drug treatment consistently benefits MSA patients in the long-term, neuroprotective or regenerative strategies are inevitable in the management of MSA patients. We divided two group, MSC-treated(n=11) and control …
-
The T Cell Response In A Mouse Model Of Multiple System Atrophy
Multiple System Atrophy (MSA) is a fatal and rare demyelinating synucleinopathy, characterized by the accumulation of alpha-synuclein (α-syn) in glial cytoplasmic inclusions (GCIs) within oligodendrocytes. This condition is marked by neuroinflammation, demyelination, and neurodegeneration in areas …
-
The Role Of B Cells In A Mouse Model Of Multiple System Atrophy
Multiple system atrophy (MSA) is a rare, fast progressing, debilitating and ultimately fatal movement disorder. The pathological hallmark of MSA disease is the aggregation and misfolding of alpha-synuclein (α-syn) protein in the cytoplasm of oligodendrocytes, termed glial cytoplasmic inclusions …
-
Dissecting the Role of the Autophagy-Lysosome Pathway in Multiple System Atrophy Pathogenesis
Η Ατροφία Πολλαπλών Συστημάτων (ΑΠΣ) είναι μια νευροεκφυλιστική ασθένεια με κυρίαρχο ιστοπαθολογικό χαρακτηριστικό τον σχηματισμό πρωτεϊνικών εγκλείστων στο κυτταρόπλασμα των ολιγοδενδροκυττάρων (γλοιακά κυτταροπλασματικά έγκλειστα), βασικό συστατικό των οποίων είναι οι πρωτεΐνες α-συνουκλεΐνη και …
-
Exosomal alpha-synuclein and TPPP/p25α: potential culprits in multiple system atrophy pathogenesis?
Η ατροφία πολλαπλών συστημάτων συνιστά μία νευροεκφυλιστική διαταραχή, η οποία χαρακτηρίζεται πρωτίστως από το σχηματισμό πρωτεϊνικών εγκλείστων εντός του κυτταροπλάσματος των ολιγοδενδροκυττάρων. Βασικά συστατικά των προαναφερθέντων εγκλείστων αποτελούν η νευρωνική πρωτεΐνη α-συνουκλεΐνη καθώς …
-
Establishment of Primary Culture Models of Multiple System Atrophy Based on Expression of a-Synuclein in Oligodendrocytes
Multiple system atrophy (MSA) is a neurodegenerative syndrome characterized by (oligodendro)glial cytoplasmic inclusions (GCIs) composed of a-synuclein. I have developed cell culture models of MSA based on overexpression of human a-synuclein in primary mouse oligodendrocytes. In oligodendrocytes …
-
Generating new models to study propagation and pathology of alpha-synuclein in Parkinson's disease and multiple system atrophy
… with familialParkinson’s disease (PD) and multiple system atrophy (MSA), as well as healthycontrols, which we extensively characterized. Using these new cellular models, wegenerated defined regionalized cellular subtypes relevant for modelling PD and MSA,such as dopaminergic neurons, …
-
CARDIAC AUTONOMIC CONTROL DURING SLEEP IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY: A PILOT STUDY ON THE IMPACT OF CPAP THERAPY
… characterize sleep-stage autonomic regulation in multiple system atrophy (MSA) using cardiorespiratory coupling (K2) and symbolic dynamics (0V%, 2UV%, 2LV%) derived from ECG tracings in video‐polysomnography (v‐PSG). The study aims to compare patients with and without sleep‐disordered breathing …
-
Head-up tilt sleeping in Parkinson disease and multiple system atrophy - Towards a better understanding and treatment of cardiovascular autonomic failure
… symptom of Parkinson's disease (PD) and multiple system atrophy (MSA) is autonomic failure, causing blood pressure problems such as orthostatic hypotension (OH) and supine hypertension. A retrospective analysis revealed that the main haemodynamic factor behind this co-occurrence is a high …
Page 1 of 4